Skip to main content
. Author manuscript; available in PMC: 2019 Apr 12.
Published in final edited form as: Leuk Res. 2011 Nov 21;36(2):140–145. doi: 10.1016/j.leukres.2011.10.018

Table 3.

Overall survival (months) by karyotype

White Black
n (%) median OS n (%) median OS p-value
All patients 370 14 97 15 0.33
t(15;17) 24 (6) * 9 (9) 55 0.57
Other favorable 23 (6) 42 9 (9) * 0.31
Normal 167 (45) 15 28 (29) 12 0.56
All intermediate 210 (57) 15 41 (42) 13 0.46
  Wild-type FLT3 45 18 6 * 0.04
  FLT3 mutation 32 10 7 7 0.68
Complex 49 (13) 7 27 (28) 8 0.48
All unfavorable 113 (31) 7 38 (39) 8 0.81
*

not reached